About

Conversely, a retrospective analysis of five men with PD and testosterone deficiency did show significant improvement of refractory non-motor PD symptoms following TRT . The study was limited by a small sample size and the lack of long-term follow-up, which may have lacked evidence surrounding any delayed effects of TRT . Parkinson disease (PD), is observed twice as frequently in men than women, typically affecting males in their fifth or sixth decade of life . Thus, there is no clear role for TRT in the prevention or treatment of MCI or dementia. Similarly, another study with a one-year follow-up reviewed the impact of TRT versus placebo in men with MCI and symptomatic hypogonadism and showed no improvement in cognitive function 47, 48. Testosterone is postulated to have a protective effect against the development of dementia, as evidenced by the higher incidence of Alzheimer disease (AD) in women, who make up two-thirds of AD patients.
• The impact of gender-affirming hormone therapy on brain structure and function. One promising area of research is using brain imaging techniques to understand better the neural mechanisms involved in sexual behaviour. Seeking therapy or counselling can help address the underlying trauma and improve sexual function. It is important to note that not all individuals who have experienced trauma will experience sexual dysfunction. These flashbacks can occur during sexual activity, leading to a loss of desire or difficulty achieving arousal. This can make it difficult to relax and feel comfortable during sexual activity, leading to difficulty achieving arousal or orgasm .
Local interaction of BDNF with the TrkB receptor on a single dendritic segment is able to stimulate an increase in PSD-95 trafficking to other separate dendrites as well as to the synapses of locally stimulated neurons. BDNF can reduce capping activities by upregulating PKC, which can bind to the adducing MRCKS domain, inhibit capping activity, and promote synaptogenesis through dendritic spine growth and disassembly and other activities. At their C-terminus, adducins possess a myristoylated alanine-rich C kinase substrate (MARCKS) domain which regulates their capping activity.
Several reviews have extensively considered and discussed this topic in the central nervous system (CNS), because the first observations were obtained in the brain 2–7. Neuroactive steroids are molecules acting in the nervous system including steroids produced by the nervous system (i.e., neurosteroids) and hormonal steroids coming from classical steroidogenic tissues (i.e., gonads and adrenal glands) . The ultimate goal of these is to improve accessibility and enable longitudinal monitoring of BDNF levels. Clinicians, such as neurologists and psychiatrists, have expressed interest in BDNF being a potential biomarker for tracking disease progression and therapeutic response.
It emphasizes the need for further research to elucidate the complex interactions between biological, psychological, and sociocultural factors in the context of human sexuality. It explores the cognitive and attentional mechanisms involved in the appraisal of sexual stimuli and discusses the discrepancies between self-reported and physiological measures of sexual arousal. Additionally, the review addresses the relationship between sexual behaviour and other cognitive processes, such as decision-making, impulse control, and memory. Androgens do not prevent striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice. Testosterone does not protect against methamphetamine-induced neurotoxicity of the dopaminergic system in mice and does not provide significant neuroprotection against glutamate-induced neurotoxicity. There are also evidences against the neuroprotective action of testosterone. Alzheimer's disease (AD), mild cognitive impairment (MCI) or depression.
Moreover, non-classical steroid receptors, such as progesterone receptor membrane component 1 (PGRMC1), GABA-A, GABA-B, NMDA, AMPA and kainate subunits, as well as sigma 1 receptor are also expressed by the different cellular components of the PNS 42,48–52. PNS is not only able to synthesize and metabolize neuroactive steroids but it is also a target for their effects. Interestingly, the levels of neuroactive steroids are different in males and females (Fig. 2), with females having higher PREG, DHP, THP, DHEA and 17β-E levels, and males having higher levels of isopregnanolone, T, DHT and 3α-diol 36–39. Moreover, Schwann cells as well as neurons in dorsal root ganglia (DRG) are capable of converting PREG further to neuroactive steroids (Fig. 1). On this basis, new therapeutic strategies based on neuroactive steroids have been recently proposed for peripheral neuropathy 10,20.
However, the impact of androgens on oxidative stress as well as the negative modulation of neurotrophins growth factors may have counterproductive detrimental effects 12, 13. Conversely, DHEA has the opposite effect than testosterone on brain development, possibly counteracting the effects of testosterone. Thus, it is hypothesized that androgens negatively impact cognitive functions regulated through these structures . The influence of androgens on brain development may begin during fetal development.

Gender: Female